Prostate Cancer: The ABCs of Initial Evaluation
(Visit: http://www.uctv.tv) Dr. Peter Carroll is co-director of urologic cancer at the UCSF Helen Diller Family Comprehensive Cancer Center and chair of the Department of Urology at UCSF. Recorded on 06/08/2019. Series: "Prostate Cancer Patient Conference" [Professional Medical Education] [Show ID: 34961]
Видео Prostate Cancer: The ABCs of Initial Evaluation канала University of California Television (UCTV)
Видео Prostate Cancer: The ABCs of Initial Evaluation канала University of California Television (UCTV)
Показать
Комментарии отсутствуют
Информация о видео
19 июня 2019 г. 1:00:00
00:19:27
Другие видео канала
Intermediate and "High-Risk" Prostate Cancer - 2019 Prostate Cancer Patient Conference
Vitamin D and Prostate Cancer
Prostate Cancer Epidemiology, Screening and Diagnosis - 2021 Prostate Cancer Patient Conference
Prostate Cancer Initial Staging and Evaluation of Recurrent Disease with PSMA-Targeted PET
There is life after prostate surgery - Patient testimonial
Prostate Carcinoma Pathology ( Morphology and Gleason Grading)
4.3.2020 Urology COViD Didactics - Prostate Cancer Screening, Diagnosis and Risk Stratification
Ben Stiller Opens Up About Prostate Cancer For First Time Since Diagnosis | TODAY
The ABCs of Androgen Deprivation Therapy
Unorthodox Treatments for High-Risk Prostate Cancer | Prostate Cancer Staging Guide
Update on prostate cancer screening guidelines
Reducing Side Effects of Hormone Therapy for Prostate Cancer | Prostate Cancer Staging Guide
Systemic Therapies for the Treatment of Advanced Prostate Cancer
Biochemical Recurrence After Local Therapy: Assessment and Management![The Prostate Health Index (phi) in Prostate Cancer Risk Assessment [Hot Topic]](https://i.ytimg.com/vi/JmQqcBvEthQ/default.jpg)
The Prostate Health Index (phi) in Prostate Cancer Risk Assessment [Hot Topic]
Prostate Cancer Treatment update 2021
Prostate MRI: Do You Need a Random Biopsy? | Off The Cuff with Mark Moyad, MD
Diet and Prostate Cancer—Now What?
Precision Radiation Therapy: Low- to Intermediate-Risk Prostate Cancer
Results of a Prostate Cancer/Vitamin D Trial: Effectiveness Safety Recommendations